ScholarLink (思领科)
错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The tumor cell-intrinsic cGAS–STING pathway is associated with the high density of CD8+ T cells after chemotherapy in esophageal squamous cell carcinoma

  • 期刊论文

  • 发表日期：

    2024年2月7日

查看全文
  • Akira Matsuishi,
  • Shotaro Nakajima,
  • Akinao Kaneta,
  • Katsuharu Saito,
  • Satoshi Fukai,
  • Mei Sakuma,
  • Hideaki Tsumuraya,
  • Hirokazu Okayama,
  • Motonobu Saito,
  • Kosaku Mimura,
  • Azuma Nirei,
  • Tomohiro Kikuchi,
  • Hiroyuki Hanayama,
  • Zenichiro Saze,
  • Wataru Sakamoto,
  • Tomoyuki Momma,
  • Koji Kono

摘要

Background

Chemotherapy has the potential to induce CD8+ T-cell infiltration in the tumor microenvironment (TME) and activate the anti-tumor immune response in several cancers including esophageal squamous cell carcinoma (ESCC). The tumor cell-intrinsic cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway has been known as a critical component for regulating immune cell activation in the TME. However, its effect on the infiltration of immune cells induced by chemotherapy in the ESCC TME has not been investigated.

Methods

We examined the effect of the tumor-cell intrinsic cGAS–STING pathway on the infiltration of CD8+ T cells induced by chemotherapy in ESCC using ESCC cell lines and surgically resected ESCC specimens from patients who received neoadjuvant chemotherapy (NAC).

Results

We found that chemotherapeutic agents, including 5-fluorouracil (5-FU) and cisplatin (CDDP), activated the cGAS–STING pathway, consequently inducing the expression of type I interferon and T-cell-attracting chemokines in ESCC cells. Moreover, the tumor cell-intrinsic expression of cGAS–STING was significantly and positively associated with the density of CD8+ T cells in ESCC after NAC. However, the tumor cell-intrinsic expression of cGAS–STING did not significantly impact clinical outcomes in patients with ESCC after NAC.

Conclusion

Our findings suggest that the tumor cell-intrinsic cGAS–STING pathway might contribute to chemotherapy-induced immune cell activation in the ESCC TME.